EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Potential prognostic role of somatic mutations in a set of cancer susceptibility genes in ovarian carcinoma: A follow-up multicentric study from Pakistan

Atika Masood, Rahat Sarfaraz, Saima Zaki, Amira Shami, Saba Khaliq, Nadia Naseem

Cancer Biomarkers · 2023

DOI: 10.3233/cbm-220267 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Biomarkers, 2023. Verfasst von Atika Masood und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histopathology and Morbid Anatomy, University of Health Sciences, Lahore, Pakistan. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Carcinoma. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Genetic mutations, peritoneal metastasis and frequent development of chemoresistance worsen the prognosis of ovarian carcinoma. OBJECTIVE: The objective of the study is to determine mutations in cancer susceptibility genes in relation with chemotherapy response. METHODS: In this follow up descriptive study, 47 consenting female patients diagnosed with surface epithelial ovarian cancer were observed for six months after completion of chemotherapy to see the treatment response. For genetic analysis, the DNA extraction was done and the genomic regions of different exons of BRCA1/2, PALB2, CHEK2, BAP1, CTNNB1, HOXB13, and PIK3CA were amplified using gene specific primers followed by Sanger Sequencing. RESULTS: 86.7% of the patients were sensitive to chemotherapy whereas 13.3% showed resistance. Genetic variants of BRCA1 in 7%, BRCA2 in 4.7%, PIK3CA in 9.3%, PALB2 in 7%, CHEK2 in 2.3%, BAP1 in 2.3%, and CTNNB1 in 2.3% of the patients were found. There was also a significant association between TNM stage and the treatment response (p< 0.01). Of the patients with no mutations, 90.9% showed chemosensitivity as opposed to 70% in mutations group. CONCLUSION: Our study exhibits the pivotal role of genetic analysis in predicting the treatment response and paving pathway for patient tailored targeted therapy in Pakistani population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCarcinomaHumansFemaleCarcinoma, Ovarian EpithelialFollow-Up StudiesPakistanPrognosisGerm-Line MutationBRCA2 ProteinBRCA1 ProteinGenetic Predisposition to Disease

Stichwörter der Autor:innen

BRCA1/2Epithelial ovarian cancerchemotherapyprognosissomatic mutations

Substanzen

BRCA2 ProteinBRCA1 Protein

Autor:innen und Institutionen

  • Department of Histopathology and Morbid Anatomy, University of Health Sciences, Lahore, Pakistan.
  • Department of Obstetrics and Gynecology, Jinnah Hospital, Lahore, Pakistan.
  • Department of Oncology, INMOL Hospital, Lahore, Pakistan.
  • Department of Physiology and Cell Biology, University of Health Sciences, Lahore, Pakistan.

Zitieren

APA

Masood, A., Sarfaraz, R., Zaki, S., Shami, A., Khaliq, S., & Naseem, N. (2023). Potential prognostic role of somatic mutations in a set of cancer susceptibility genes in ovarian carcinoma: A follow-up multicentric study from Pakistan. Cancer Biomarkers. https://doi.org/10.3233/cbm-220267

Vancouver

Masood A, Sarfaraz R, Zaki S, Shami A, Khaliq S, Naseem N. Potential prognostic role of somatic mutations in a set of cancer susceptibility genes in ovarian carcinoma: A follow-up multicentric study from Pakistan. Cancer Biomarkers. 2023. doi:10.3233/cbm-220267

BibTeX
@article{Masood2023,
  author = {Masood, Atika and Sarfaraz, Rahat and Zaki, Saima and Shami, Amira and Khaliq, Saba and Naseem, Nadia},
  title = {Potential prognostic role of somatic mutations in a set of cancer susceptibility genes in ovarian carcinoma: A follow-up multicentric study from Pakistan},
  journal = {Cancer Biomarkers},
  year = {2023},
  doi = {10.3233/cbm-220267}
}
Kostenlos starten →